Where Does Liquidia Stock Rank Among Competitors?
Liquidia (LQDA) stock has soared, returning 126% over the past year, dwarfing large-cap pharma peers. Yet, against established giants, LQDA, with its tiny $2.97 billion market cap, battles for profitability. It boasts explosive LTM revenue growth of 343% but struggles with deeply negative operating (-155%) and free cash flow margins (-156%) and a negative PE ratio (-23.9). Sustained upside hinges heavily on successful product commercialization and scaling amidst competition in the biopharmaceutical industry.
- LQDA’s -155.0% operating margin, lowest among peers (LLY: 45.6%), signals heavy R&D for pipeline development, typical for emerging biotech.
- LQDA’s 343.4% revenue growth outpaces peers, indicating successful new product uptake, while large pharma like LLY faces slower market expansion.
- LQDA’s 126.3% gain and -23.9 P/E reflect investor optimism for future products, a common trend for high-growth biotechs vs. mature pharma.
Here’s how Liquidia stacks up across size, valuation, and profitability versus key peers.
| LQDA | LLY | JNJ | MRK | PFE | BMY | |
|---|---|---|---|---|---|---|
| Market Cap ($ Bil) | 3.0 | 899.0 | 590.6 | 298.4 | 151.4 | 126.8 |
| Revenue ($ Bil) | 0.1 | 65.2 | 94.2 | 65.0 | 62.6 | 48.2 |
| PE Ratio | -23.9 | 43.6 | 22.0 | 16.3 | 19.5 | 18.0 |
| LTM Revenue Growth | 343.4% | 44.7% | 6.0% | 1.3% | -1.6% | -0.2% |
| LTM Operating Margin | -155.0% | 45.6% | 27.2% | 34.0% | 27.8% | 28.5% |
| LTM FCF Margin | -155.8% | 9.2% | 20.5% | 19.0% | 14.5% | 26.7% |
| 12M Market Return | 126.3% | 11.0% | 52.4% | 34.8% | 10.9% | 10.2% |
For more details on Liquidia, read Buy or Sell LQDA Stock. Below we compare LQDA’s growth, margin, and valuation with peers across years
Revenue Growth Comparison
- Get Paid 9.0% to Buy ADSK at a 30% Discount – Here’s How
- The Smart Way to Own LLY: Collect 8.8% Before You Even Buy
- Cash Machine Trading Cheap – GoDaddy Stock Set to Run?
- Meta Platforms Stock Capital Return Hits $184 Bil
- Eli Lilly Stock Hands $51 Bil Back – Worth a Look?
- Alphabet Stock Hands $364 Bil Back – Worth a Look?
| LTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| LQDA | 343.4% | – | -20.0% | 9.7% | 24.0% |
| LLY | 44.7% | 44.7% | 32.0% | 19.6% | |
| JNJ | 6.0% | 6.0% | 4.3% | 6.5% | |
| MRK | 1.3% | 1.3% | 6.7% | 1.4% | |
| PFE | -1.6% | -1.6% | 6.8% | -41.1% | |
| BMY | -0.2% | -0.2% | 7.3% | -2.5% |
Operating Margin Comparison
| LTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| LQDA | -155.0% | – | -866.6% | -419.6% | -243.3% |
| LLY | 45.6% | 45.6% | 37.8% | 30.3% | |
| JNJ | 27.2% | 27.2% | 23.9% | 25.8% | |
| MRK | 34.0% | 34.0% | 31.5% | 4.9% | |
| PFE | 27.8% | 27.8% | 23.5% | 7.4% | |
| BMY | 28.5% | 28.5% | 12.2% | 18.2% |
PE Ratio Comparison
| LTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| LQDA | -23.9 | – | -20.8 | -9.7 | -17.9 |
| LLY | 43.6 | 46.7 | 65.7 | 100.1 | |
| JNJ | 22.0 | 18.6 | 24.8 | 11.3 | |
| MRK | 16.3 | 14.4 | 14.7 | 757.8 | |
| PFE | 19.5 | 18.2 | 18.7 | 76.7 | |
| BMY | 18.0 | 15.6 | -12.8 | 13.2 |
Still not sure about LQDA stock? Consider portfolio approach.
Smart Investing Begins With Portfolios
Single stocks swing wildly but staying invested matters. A well built portfolio helps you stay invested, captures upside and softens the blows from individual stocks.
Why settle for average market returns? The Trefis High Quality (HQ) Portfolio invests in a diverse group of 30 stocks that have collectively delivered stronger upside with reduced volatility compared to the broader indices. Discover the methodology behind these smoother, higher returns by checking the HQ Portfolio performance data.